Protagonist Therapeutics, Inc - Common Stock (PTGX)
CUSIP: 74366E102
Q1 2020 13F Holders as of 31 Mar 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 62,457,444
- Total 13F shares
- 23,373,035
- Share change
- +174,396
- Total reported value
- $165,030,731
- Price per share
- $7.06
- Number of holders
- 75
- Value change
- +$1,225,355
- Number of buys
- 34
- Number of sells
- 36
Quarterly Holders Quick Answers
What is CUSIP 74366E102?
CUSIP 74366E102 identifies PTGX - Protagonist Therapeutics, Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74366E102:
Top shareholders of PTGX - Protagonist Therapeutics, Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
6.5%
|
4,080,967
|
$28,771,000 | — | 31 Dec 2019 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
3.9%
|
2,459,988
|
$17,343,000 | — | 31 Dec 2019 | |
| Johnson & Johnson Innovation - JJDC, Inc. |
13F
|
Company |
3.9%
|
2,449,183
|
$17,267,000 | — | 31 Dec 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.5%
|
1,561,957
|
$11,012,000 | — | 31 Dec 2019 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.4%
|
1,500,000
|
$10,575,000 | — | 31 Dec 2019 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.9%
|
1,174,282
|
$8,279,000 | — | 31 Dec 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.6%
|
989,785
|
$6,978,000 | — | 31 Dec 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.4%
|
846,994
|
$5,971,000 | — | 31 Dec 2019 | |
| BVF INC/IL |
13F
|
Company |
1.1%
|
682,630
|
$4,813,000 | — | 31 Dec 2019 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.1%
|
670,751
|
$4,729,000 | — | 31 Dec 2019 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
1%
|
630,000
|
$4,442,000 | — | 31 Dec 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.99%
|
618,124
|
$4,358,000 | — | 31 Dec 2019 | |
| Novo Holdings A/S |
13F
|
Company |
0.77%
|
479,074
|
$3,377,000 | — | 31 Dec 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.74%
|
459,093
|
$3,236,000 | — | 31 Dec 2019 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.69%
|
430,517
|
$3,035,000 | — | 31 Dec 2019 | |
| STATE STREET CORP |
13F
|
Company |
0.54%
|
338,170
|
$2,384,000 | — | 31 Dec 2019 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.51%
|
319,000
|
$2,249,000 | — | 31 Dec 2019 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.44%
|
275,000
|
$1,939,000 | — | 31 Dec 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.43%
|
270,598
|
$1,907,000 | — | 31 Dec 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.41%
|
258,434
|
$1,822,000 | — | 31 Dec 2019 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.4%
|
250,000
|
$1,763,000 | — | 31 Dec 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.39%
|
245,676
|
$1,732,000 | — | 31 Dec 2019 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.33%
|
203,884
|
$1,437,000 | — | 31 Dec 2019 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.31%
|
194,437
|
$1,370,000 | — | 31 Dec 2019 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.31%
|
191,209
|
$1,348,000 | — | 31 Dec 2019 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.15%
|
93,103
|
$656,000 | — | 31 Dec 2019 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.15%
|
91,831
|
$647,000 | — | 31 Dec 2019 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
91,144
|
$643,000 | — | 31 Dec 2019 | |
| WINTON GROUP Ltd |
13F
|
Company |
0.14%
|
89,856
|
$633,000 | — | 31 Dec 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
83,582
|
$589,000 | — | 31 Dec 2019 | |
| VHCP Management III, LLC |
13F
|
Company |
0.13%
|
80,929
|
$571,000 | — | 31 Dec 2019 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.13%
|
78,326
|
$552,000 | — | 31 Dec 2019 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.12%
|
72,001
|
$507,000 | — | 31 Dec 2019 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.11%
|
67,186
|
$474,000 | — | 31 Dec 2019 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.1%
|
62,166
|
$438,000 | — | 31 Dec 2019 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.08%
|
51,690
|
$365,000 | — | 31 Dec 2019 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.08%
|
47,568
|
$334,000 | — | 31 Dec 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.07%
|
43,753
|
$309,000 | — | 31 Dec 2019 | |
| PDT Partners, LLC |
13F
|
Company |
0.07%
|
43,406
|
$306,000 | — | 31 Dec 2019 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.07%
|
42,516
|
$300,000 | — | 31 Dec 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.05%
|
33,478
|
$237,000 | — | 31 Dec 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
33,329
|
$235,000 | — | 31 Dec 2019 | |
| VHCP Management II, LLC |
13F
|
Company |
0.05%
|
32,211
|
$227,000 | — | 31 Dec 2019 | |
| WELD CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.05%
|
31,488
|
$222,000 | — | 31 Dec 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.05%
|
28,231
|
$197,000 | — | 31 Dec 2019 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
26,542
|
$187,000 | — | 31 Dec 2019 | |
| Spark Investment Management LLC |
13F
|
Company |
0.04%
|
23,900
|
$168,000 | — | 31 Dec 2019 | |
| FRANKLIN STREET ADVISORS INC /NC |
13F
|
Company |
0.04%
|
23,500
|
$166,000 | — | 31 Dec 2019 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.04%
|
22,800
|
$161,000 | — | 31 Dec 2019 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.04%
|
22,687
|
$160,000 | — | 31 Dec 2019 |
Institutional Holders of Protagonist Therapeutics, Inc - Common Stock (PTGX) as of Q1 2020
As of 31 Mar 2020,
Protagonist Therapeutics, Inc - Common Stock (PTGX) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,373,035 shares.
The largest 10 holders included
FMR LLC, RTW INVESTMENTS, LP, Johnson & Johnson Innovation - JJDC, Inc., BAKER BROS. ADVISORS LP, BlackRock Inc., FARALLON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, JPMORGAN CHASE & CO, Novo Holdings A/S, and BVF INC/IL.
This page lists
75
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2020 vs Q4 2019 Across Filers
Q4 2019 holders
79
Q1 2020 holders
75
Holder diff
-4
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 Value $ | Q1 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.